DigitalOcean (DOCN) 10-Q 8 Aug 22 2022 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Jun. 30, 2022	Jul. 28, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2022
Document Transition Report	false
Entity File Number	001-40252
Entity Registrant Name	DigitalOcean Holdings, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	45-5207470
Entity Address, Address Line One	101 6th Avenue
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10013
City Area Code	646
Local Phone Number	827-4366
Title of 12(b) Security	Common stock, par value $0.000025 per share
Trading Symbol	DOCN
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		96,930,317
Entity Central Index Key	0001582961
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--12-31

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 72,177	$ 1,713,387
Marketable securities	1,093,977	0
Accounts receivable, less allowance for doubtful accounts of $5,315 and $4,212, respectively	44,056	39,619
Prepaid expenses and other current assets	20,922	17,050
Total current assets	1,231,132	1,770,056
Noncurrent assets:
Property and equipment, net	268,418	249,643
Restricted cash	1,935	2,038
Goodwill	32,170	32,170
Intangible assets, net	52,205	42,915
Deferred tax assets	86	88
Other assets	4,762	4,085
Total assets	1,590,708	2,100,995
Current liabilities:
Accounts payable	17,759	12,657
Accrued other expenses	39,023	31,907
Deferred revenue	4,734	4,826
Other current liabilities	12,711	8,849
Total current liabilities	74,227	58,239
Noncurrent liabilities:
Deferred tax liabilities	421	421
Long-term debt	1,466,519	1,462,676
Other long-term liabilities	1,268	1,462
Total liabilities	1,542,435	1,522,798
Commitments and Contingencies (Note 8)
Preferred stock ($0.000025 par value per share; 10,000,000 shares authorized; 0 shares issued and outstanding as of June 30, 2022 and December 31, 2021)	0	0
Common stock ($0.000025 par value per share; 750,000,000 shares authorized; 98,856,183 and 109,175,863 issued; and 96,887,955 and 107,207,635 outstanding as of June 30, 2022 and December 31, 2021, respectively)	2	2
Treasury stock, at cost (1,968,228 shares at June 30, 2022 and December 31, 2021)	(4,598)	(4,598)
Additional paid-in capital	268,689	769,705
Accumulated other comprehensive loss	(4,968)	(374)
Accumulated deficit	(210,852)	(186,538)
Total stockholders’ equity	48,273	578,197
Total liabilities and stockholders’ equity	$ 1,590,708	$ 2,100,995

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Statement [Abstract]
Revenue	$ 133,882	$ 103,810	$ 261,209	$ 197,471
Cost of revenue	47,246	43,145	94,003	82,689
Gross profit	86,636	60,665	167,206	114,782
Operating expenses:
Research and development	36,956	27,121	74,197	49,523
Sales and marketing	18,219	11,812	37,263	22,233
General and administrative	38,838	24,362	76,262	42,402
Total operating expenses	94,013	63,295	187,722	114,158
(Loss) income from operations	(7,377)	(2,630)	(20,516)	624
Other (income) expense:
Interest expense	2,095	233	4,154	2,489
Loss on extinguishment of debt	0	0	407	3,435
Other (income) expense, net	(2,112)	(203)	(2,932)	(297)
Other (income) expense	(17)	30	1,629	5,627
Loss before income taxes	(7,360)	(2,660)	(22,145)	(5,003)
Income tax (benefit) expense	(1,169)	(473)	2,169	523
Net loss attributable to common stockholders	$ (6,191)	$ (2,187)	$ (24,314)	$ (5,526)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.06)	$ (0.02)	$ (0.23)	$ (0.07)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.06)	$ (0.02)	$ (0.23)	$ (0.07)
Weighted-average shares used to compute net loss per share, basic (in shares)	102,502,000	106,765,000	104,697,000	78,257,000
Weighted average shares used to compute net loss per share, diluted (in shares)	102,502,000	106,765,000	104,697,000	78,257,000

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Statement of Other Comprehensive Income [Abstract]
Net loss attributable to common stockholders	$ (6,191)	$ (2,187)	$ (24,314)	$ (5,526)
Other comprehensive loss:
Foreign currency translation adjustments, net of taxes	(188)	(40)	(206)	(28)
Unrealized loss on available-for-sale marketable securities, net of taxes	(2,480)		(4,388)	0
Comprehensive loss	$ (8,859)	$ (2,227)	$ (28,908)	$ (5,554)

Consolidated Statements of Conv

Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-In Capital	Accumulated Other Comprehen-sive Loss	Accumulated Deficit
Convertible preferred stock outstanding at beginning of period (in shares) at Dec. 31, 2020	45,472,229
Convertible preferred stock outstanding at beginning of period at Dec. 31, 2020	$ 173,074
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of convertible preferred stock (in shares)	(45,472,229)
Issuance of convertible preferred stock	$ (173,074)
Convertible preferred stock outstanding at end of period (in shares) at Jun. 30, 2021	0
Convertible preferred stock outstanding at end of period at Jun. 30, 2021	$ 0
Beginning Balance (in shares) at Dec. 31, 2020		45,299,339
Beginning Balance at Dec. 31, 2020	(72,094)	$ 1	$ 4,598	$ 99,783	$ (245)	$ (167,035)
Beginning Balance (in shares) at Dec. 31, 2020			(1,968,228)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under equity incentive plan, net of taxes withheld (in shares)		1,877,797
Issuance of common stock under equity incentive plan, net of taxes withheld	6,480			6,480
Exercise of common stock warrants (in shares)		64,328
Exercise of common stock warrants	0
Stock-based compensation	19,146	$ 19,146
Issuance of common stock in connection with initial public offering, net of underwriting discounts and issuance costs (in shares)		16,500,000
Issuance of common stock in connection with initial public offering, net of underwriting discounts and issuance costs	723,126	$ 1		723,125
Issuance of convertible preferred stock (in shares)		45,472,229
Issuance of convertible preferred stock	173,074			173,074
Conversion of convertible preferred stock to common stock in connection with initial public offering	13,906			13,906
Other comprehensive loss	(28)				(28)
Net loss attributable to common stockholders	(5,526)					(5,526)
Ending Balance (in shares) at Jun. 30, 2021		109,213,693
Ending Balance at Jun. 30, 2021	$ 858,084	$ 2	$ 4,598	1,035,514	(273)	(172,561)
Ending Balance (in shares) at Jun. 30, 2021			(1,968,228)
Convertible preferred stock outstanding at end of period (in shares) at Jun. 30, 2021	0
Convertible preferred stock outstanding at end of period at Jun. 30, 2021	$ 0
Beginning Balance (in shares) at Mar. 31, 2021		108,305,374
Beginning Balance at Mar. 31, 2021	845,110	$ 2	$ 4,598	1,020,313	(233)	(170,374)
Beginning Balance (in shares) at Mar. 31, 2021			(1,968,228)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under equity incentive plan, net of taxes withheld (in shares)		843,991
Issuance of common stock under equity incentive plan, net of taxes withheld	2,740			2,740
Exercise of common stock warrants (in shares)		64,328
Exercise of common stock warrants	0
Stock-based compensation	12,461			12,461
Other comprehensive loss	(40)				(40)
Net loss attributable to common stockholders	(2,187)					(2,187)
Ending Balance (in shares) at Jun. 30, 2021		109,213,693
Ending Balance at Jun. 30, 2021	$ 858,084	$ 2	$ 4,598	1,035,514	(273)	(172,561)
Ending Balance (in shares) at Jun. 30, 2021			(1,968,228)
Beginning Balance (in shares) at Dec. 31, 2021	107,207,635	109,175,863
Beginning Balance at Dec. 31, 2021	$ 578,197	$ 2	$ 4,598	769,705	(374)	(186,538)
Beginning Balance (in shares) at Dec. 31, 2021			(1,968,228)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under equity incentive plan, net of taxes withheld (in shares)	1,437,868	2,083,397
Issuance of common stock under equity incentive plan, net of taxes withheld	$ (11,222)			(11,222)
Issuance of common stock under employee stock purchase plan, net of taxes withheld (in shares)		144,867
Issuance of common stock under employee stock purchase plan, net of taxes withheld	$ 5,244			5,244
Repurchase and retirement of common stock (in shares)	(12,547,944)	(12,547,944)
Repurchase and retirement of common stock	$ (550,000)			(550,000)
Stock-based compensation	54,962			54,962
Other comprehensive loss	(4,594)				(4,594)
Net loss attributable to common stockholders	$ (24,314)					(24,314)
Ending Balance (in shares) at Jun. 30, 2022	96,887,955	98,856,183
Ending Balance at Jun. 30, 2022	$ 48,273	$ 2	$ 4,598	268,689	(4,968)	(210,852)
Ending Balance (in shares) at Jun. 30, 2022			(1,968,228)
Beginning Balance (in shares) at Mar. 31, 2022		107,956,057
Beginning Balance at Mar. 31, 2022	427,831	$ 2	$ 4,598	639,388	(2,300)	(204,661)
Beginning Balance (in shares) at Mar. 31, 2022			(1,968,228)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under equity incentive plan, net of taxes withheld (in shares)		725,732
Issuance of common stock under equity incentive plan, net of taxes withheld	(4,513)			(4,513)
Issuance of common stock under employee stock purchase plan, net of taxes withheld (in shares)		144,867
Issuance of common stock under employee stock purchase plan, net of taxes withheld	$ 5,244			5,244
Repurchase and retirement of common stock (in shares)	(9,970,473)	(9,970,473)
Repurchase and retirement of common stock	$ (400,000)			(400,000)
Stock-based compensation	28,570			28,570
Other comprehensive loss	(2,668)				(2,668)
Net loss attributable to common stockholders	$ (6,191)					(6,191)
Ending Balance (in shares) at Jun. 30, 2022	96,887,955	98,856,183
Ending Balance at Jun. 30, 2022	$ 48,273	$ 2	$ 4,598	$ 268,689	$ (4,968)	$ (210,852)
Ending Balance (in shares) at Jun. 30, 2022			(1,968,228)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Operating activities
Net loss attributable to common stockholders	$ (24,314)	$ (5,526)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	48,274	42,541
Stock-based compensation	54,164	18,825
Bad debt expense	8,070	3,467
Loss on extinguishment of debt	407	3,435
Net accretion of discounts and amortization of premiums on investments	(1,027)	0
Non-cash interest expense	3,918	296
Loss on impairment	120	0
Revaluation of warrants	0	(556)
Other	739	(41)
Changes in operating assets and liabilities, net of acquisition:
Accounts receivable	(12,507)	(9,287)
Prepaid expenses and other current assets	(3,872)	1,563
Accounts payable and accrued expenses	(401)	3,767
Deferred revenue	(93)	157
Other assets and liabilities	2,174	1,556
Net cash provided by operating activities	75,652	60,197
Investing activities
Capital expenditures - property and equipment	(48,041)	(47,036)
Capital expenditures - internal-use software development	(4,330)	(2,713)
Purchase of intangible assets	(4,915)	0
Cash paid for asset acquisitions	(5,400)	0
Purchase of available-for-sale securities	(1,257,106)	0
Maturities of available-for-sale securities	159,878	0
Purchased interest on available-for-sale securities	(1,549)	0
Proceeds from interest on available-for-sale securities	1,370	0
Proceeds from sale of equipment	909	81
Net cash used in investing activities	(1,159,184)	(49,668)
Financing activities
Repayment of notes payable	0	(33,214)
Repayment of term loan	0	(166,813)
Repayment of borrowings under revolving credit facility	0	(63,200)
Payment of debt issuance costs	(1,492)	0
Proceeds related to the issuance of common stock under equity incentive plan	8,553	7,487
Proceeds from the issuance of common stock under employee stock purchase plan	5,152	0
Employee payroll taxes paid related to net settlement of equity awards	(19,995)	(1,007)
Proceeds from initial public offering, net of underwriting discounts and commissions and other offering costs	0	723,125
Repurchase and retirement of common stock	(550,000)	0
Net cash (used in) provided by financing activities	(557,782)	466,378
(Decrease) increase in cash, cash equivalents and restricted cash	(1,641,313)	476,907
Cash, cash equivalents and restricted cash - beginning of period	1,715,425	102,537
Cash, cash equivalents and restricted cash - end of period	74,112	579,444
Supplemental disclosures of cash flow information:
Cash paid for interest	221	2,152
Cash paid for taxes (net of refunds)	1,108	633
Non-cash investing and financing activities:
Capitalized stock-based compensation	798	321
Property and equipment received but not yet paid, included in Accounts payable and Accrued other expenses	26,069	14,407
Debt issuance costs included in accounts payable and accrued liabilities	$ 18	$ 0

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 5,315	$ 4,212
Preferred stock, par value (in usd per share)	$ 0.000025	$ 0.000025
Preferred stock, shares authorized (in shares)	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)		$ 0.000025
Common stock, shares authorized (in shares)	750,000,000
Common stock, shares issued (in shares)	98,856,183	109,175,863
Common stock, shares outstanding (in shares)	96,887,955	107,207,635
Treasury stock, shares (in shares)	1,968,228	1,968,228

Nature of the Business and Orga

Nature of the Business and Organization	6 Months Ended
	Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of the Business and Organization	Nature of the Business and OrganizationDigitalOcean Holdings, Inc. and its subsidiaries (collectively, the “Company”, “we”, “our”, “us”) is a leading cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups and small-to-medium size businesses. The Company was founded with the guiding principle that the transformative benefits of the cloud should be easy to leverage, broadly accessible, reliable and affordable. The Company’s platform simplifies cloud computing, enabling its customers to rapidly accelerate innovation and increase their productivity and agility. The Company offers mission-critical infrastructure solutions across compute, storage and networking, and also enables developers to extend the native capabilities of the Company’s cloud with fully managed application, container and database offerings.The Company has adopted a holding company structure and the primary operations are performed globally through our wholly-owned operating subsidiaries.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation and Principles of Consolidation The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and include accounts of the Company and all wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, which include normal recurring adjustments, necessary for a fair statement of the Company’s financial position as of June 30, 2022, results of operations for the three and six months ended June 30, 2022 and 2021, cash flows for the six months ended June 30, 2022 and 2021, and stockholders' equity for the three and six months ended June 30, 2022 and 2021. Use of Estimates The preparation of these condensed consolidated financial statements in conformity with U.S. GAAP requires management to make, on an ongoing basis, estimates, judgments and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Such estimates include, but are not limited to, those related to revenue recognition and allowance for doubtful accounts, useful lives and realizability of long-lived assets, capitalized internal-use software development costs, accounting for stock-based compensation, valuation allowances against deferred tax assets, fair value of marketable securities, the fair value and useful lives of tangible and intangible assets acquired and liabilities assumed resulting from business combinations. Management bases its estimates on historical experience and on various other assumptions which management believes to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Restricted Cash Restricted cash includes deposits in financial institutions related to letters of credit used to secure lease agreements. The following table reconciles cash, cash equivalents and restricted cash per the Condensed Consolidated Statements of Cash Flows: June 30, 2022 2021 Cash and cash equivalents $ 72,177 $ 577,218 Restricted cash 1,935 2,226 Total cash, cash equivalents and restricted cash $ 74,112 $ 579,444 Marketable Securities The Company’s marketable securities consist of commercial paper, U.S. treasury securities and commercial debt securities. The Company determines the appropriate classification of its marketable securities at the time of purchase and reevaluates such designation at each balance sheet date. The Company has classified and accounted for its marketable securities as available-for-sale securities as the Company may sell these securities at any time for use in its current operations or for other purposes, even prior to maturity. As a result, the Company classifies its marketable securities within Current assets on the Condensed Consolidated Balance Sheets. Available-for-sale securities are recorded at fair value each reporting period. Premiums and discounts are amortized or accreted over the life of the related available-for-sale security as an adjustment to yield using the effective interest method. Interest income is recognized when earned. Unrealized gains and losses on these marketable securities are presented net of tax and reported as a separate component of Accumulated other comprehensive loss until realized. Realized gains and losses are determined based on the specific identification method and are reported in Other (income) expense, net in the Condensed Consolidated Statements of Operations. The Company periodically evaluates its marketable securities to assess whether an investment’s fair value is less than its amortized cost basis and if the decline in the fair value is attributable to a credit loss. Declines in fair value judged to be related to credit loss are reported in Other (income) expense, net in the Condensed Consolidated Statements of Operations. Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable primarily represents revenue recognized that was not invoiced at the balance sheet date and is primarily billed and collected in the following month. Trade accounts receivable are carried at the original invoiced amount less an estimated allowance for doubtful accounts based on the probability of future collection. Management determines the adequacy of the allowance based on historical loss patterns, the number of days that customer invoices are past due and an evaluation of the potential risk of loss associated with specific accounts. When management becomes aware of circumstances that may further decrease the likelihood of collection, it records a specific allowance against amounts due, which reduces the receivable to the amount that management reasonably believes will be collected. The Company records changes in the estimate to the allowance for doubtful accounts through bad debt expense and reverses the allowance after the potential for recovery is considered remote. The following table presents the changes in our allowance for doubtful accounts for the period presented: Amount Balance as of December 31, 2021 $ 4,212 Bad debt expense, net of recoveries 8,070 Write-offs (6,967) Balance as of June 30, 2022 $ 5,315 Deferred Revenue Deferred revenue was $4,734 and $4,826 as of June 30, 2022 and December 31, 2021, respectively. Revenue recognized during the three months ended June 30, 2022 and 2021 was $770 and $634, respectively, and $2,505 and $2,359 during the six months ended June 30, 2022 and 2021, respectively, which was included in each deferred revenue balance at the beginning of each respective period. Asset Acquisition The Company applies the principles provided in ASC 805, Business Combinations ("ASC 805") to determine whether a transaction involves an asset or a business. If it is determined an acquisition is an asset acquisition, the purchase consideration (which will include certain transaction costs) is allocated to the acquired assets and liabilities based on their relative fair values. In March 2022, the Company acquired the assets of the CSS Tricks website (“CSS Tricks”) from Midwest Coast Studios LLC for total purchase consideration of $4,000. The intangible assets will be amortized over 3 to 5 years. In June 2022, the Company acquired intangible assets from JournalDev IT Services Private Limited for total purchase consideration of $1,400 to be amortized over 3 years. Segment Information The Company’s chief operating decision maker, the chief executive officer, reviews discrete financial information presented on a consolidated basis for purposes of regularly making operating decisions, allocation of resources, and assessing financial performance. Accordingly, the Company has one operating and reporting segment. Geographical Information Revenue, as determined based on the billing address of the Company’s customers, was as follows: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 North America 38 % 38 % 38 % 38 % Europe 29 29 29 29 Asia 23 23 23 23 Other 10 10 10 10 Total 100 % 100 % 100 % 100 % Revenue derived from customers in the United States was 32% of total revenue for the three and six months ended June 30, 2022 and 31% of total revenue for the three and six months ended June 30, 2021. No country outside of the United States had revenue greater than 10% of total consolidated revenue in any period presented. Property and equipment located in the United States was 48% and 50% as of June 30, 2022 and December 31, 2021, respectively, with the remainder of net assets residing in international locations, primarily in the Netherlands, Singapore and Germany. Concentration of Credit Risk The amounts reflected in the Condensed Consolidated Balance Sheets for cash and cash equivalents, marketable securities, restricted cash, and trade accounts receivable are exposed to concentrations of credit risk. Although the Company maintains cash and cash equivalents with multiple financial institutions, the deposits, at times, may exceed federally insured limits. The Company believes that the financial institutions that hold its cash and cash equivalents are financially sound and, accordingly, minimal credit risk exists with respect to these balances. The Company’s customer base consists of a significant number of geographically dispersed customers. No customer represented 10% or more of accounts receivable, net as of June 30, 2022 and December 31, 2021. Additionally, no customer accounted for 10% or more of total revenue during the three and six months ended June 30, 2022 and 2021. Sublease A sublease liability is recorded when the Company ceases to use leased space, which is included as Other current liabilities and Other noncurrent liabilities on the Condensed Consolidated Balance Sheets. A sublease loss is calculated as the present value of lease payments, net of expected sublease income, and other costs that do not have future economic benefit to the Company. The sublease loss is included in General and administrative on the Condensed Consolidated Statements of Operations. Recent Accounting Pronouncements – Pending Adoption The following effective dates represent the requirements for private companies which the Company has elected as an emerging growth company. In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2016-02, Leases (Topic 842), and additional changes, modifications, clarifications, or interpretations related to this guidance thereafter (“ASU 2016-02”). ASU 2016-02 requires a reporting entity to recognize right-of-use assets and lease liabilities on the balance sheet for operating leases to increase transparency and comparability. ASU 2016-02 is effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022 with early adoption permitted. The Company expects to elect the package of transition practical expedients, which allows it to carry forward its historical assessment of (1) whether contracts are or contain leases, (2) lease classification, and (3) initial direct costs. In addition, the Company expects to elect the practical expedient that allows lessees the option to account for lease and non-lease components together as a single component for all classes of underlying assets. The Company has made substantial progress in executing its implementation plan. It is in the process of revising its controls and processes to address the lease standard and is in the process of completing the implementation and data input for the lease accounting software tool that it will use post-adoption. ASU 2016-02 also requires expanded disclosure regarding the amounts, timing and uncertainties of cash flows related to a company’s lease portfolio. The Company is evaluating these disclosure requirements and is incorporating the collection of relevant data into its existing financial reporting processes. While the Company expects the adoption of this standard to result in an increase to the reported assets and liabilities, the Company is currently evaluating the impact of adoption on the condensed consolidated financial statements. In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805) Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (“ASU 2021-08”), to improve the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to the recognition of an acquired contract liability and to payment terms and their effect on subsequent revenue recognized by the acquirer. The amendments in ASU 2021-08 require that an entity (acquirer) recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. At the acquisition date, an acquirer should account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts. ASU 2021-08 is effective for fiscal years beginning after December 15, 2023 and early adoption is permitted. While the Company is continuing to assess the timing of adoption and the potential impacts of ASU 2021-08, it does not expect ASU 2021-08 to have a material effect on its consolidated financial statements and disclosures. In June 2016, the FASB issued ASU 2016-13, with subsequent amendments, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 requires immediate recognition of management’s estimates of current expected credit losses. ASU 2016-13 is effective for annual reporting periods beginning after December 15, 2022, and interim periods within annual periods beginning after December 15, 2023, with early adoption permitted. The Company is currently evaluating the impact of adoption on the condensed consolidated financial statements. Recent Accounting Pronouncements – Adopted In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”). ASU 2019-12 eliminates certain exceptions in FASB Topic 740: Income Taxes (“ASC 740”) related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other aspects of the accounting for income taxes. ASU 2019-12 is effective for annual reporting periods beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022, with early adoption permitted. The Company adopted the new standard and there was an immaterial impact to the condensed consolidated financial statements and related disclosures.

Balance Sheet Details

Balance Sheet Details	6 Months Ended
	Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Details	Balance Sheet Details Property and equipment, net Property and equipment, net consisted of the following: June 30, 2022 December 31, 2021 Computers and equipment $ 544,056 $ 487,484 Furniture and fixtures 1,511 1,511 Leasehold improvements 6,820 6,820 Internal-use software 73,329 68,321 Property and equipment, gross $ 625,716 $ 564,136 Less: accumulated amortization $ (55,491) $ (49,268) Less: accumulated depreciation (301,807) (265,225) Property and equipment, net $ 268,418 $ 249,643 Depreciation expense on property and equipment for the three months ended June 30, 2022 and 2021 was $20,701 and $18,171, respectively, and $41,027 and $35,390 for the six months ended June 30, 2022 and 2021, respectively. The Company capitalized costs related to the development of computer software for internal use of $5,128 and $3,034 for the six months ended June 30, 2022 and 2021, respectively, which is included in internal-use software costs within Property and equipment, net. Amortization expense related to internal-use software for the three months ended June 30, 2022 and 2021 was $3,077 and $3,343, respectively, and $6,222 and $7,000 for the six months ended June 30, 2022 and 2021, respectively. During the six months ended June 30, 2022, the Company recorded an impairment loss of $120 related to software that is no longer being used. There was no such impairment loss recorded for the three months ended June 30, 2022 or the three and six months ended June 30, 2021. This impairment loss is included in Cost of revenue and Research and development on the Condensed Consolidated Statements of Operations.

Marketable Securities

Marketable Securities	6 Months Ended
	Jun. 30, 2022
Investments, Debt and Equity Securities [Abstract]
Marketable Securities	Marketable Securities The following is a summary of available-for-sale marketable securities, excluding those securities classified within cash and cash equivalents, on the Condensed Consolidated Balance Sheets as of June 30, 2022. The Company did not hold any available-for-sale marketable securities as of December 31, 2021. June 30, 2022 Amortized Gross Unrealized Gains Gross Unrealized Losses Fair U.S. treasury securities $ 708,226 $ 7 $ (2,783) $ 705,450 Corporate debt securities 35,121 — (297) 34,823 Commercial paper 355,018 — (1,314) 353,704 Total Marketable securities $ 1,098,365 $ 7 $ (4,394) $ 1,093,977 Interest income from investments was $2,644 and $6 for the three months ended June 30, 2022 and 2021, respectively, and $3,590 and $9 for the six months ended June 30, 2022 and 2021, respectively. As of June 30, 2022, all of the Company’s available-for-sale short-term investments were due within one year. The Company does not believe that any unrealized losses are attributable to credit-related factors based on its evaluation of available evidence. To determine whether a decline in value is related to credit loss, the Company evaluates, among other factors: the extent to which the fair value is less than the amortized cost basis, changes to the rating of the

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The fair value of our financial assets measured on a recurring basis is as follows: June 30, 2022 Level I Level II Total Cash and cash equivalents: Cash $ 68,551 $ — $ 68,551 Money market funds 3,626 — 3,626 Total Cash and cash equivalents $ 72,177 $ — $ 72,177 Marketable securities: U.S. treasury securities $ 705,450 $ — $ 705,450 Corporate debt securities — 34,823 34,823 Commercial paper — 353,704 353,704 Total Marketable securities $ 705,450 $ 388,527 $ 1,093,977 December 31, 2021 Level I Level II Total Cash and cash equivalents: Cash $ 1,093,425 $ — $ 1,093,425 Commercial paper — 269,945 269,945 Certificate of deposits — 350,017 350,017 Total Cash and cash equivalents $ 1,093,425 $ 619,962 $ 1,713,387 The Company classifies its highly liquid money market funds and U.S. treasury securities within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. The Company classifies its commercial paper, corporate debt securities and certificates of deposit within Level 2 because they are valued using inputs other than quoted prices that are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security which may not be actively traded. The Company had no level 3 financial assets as of June 30, 2022 and December 31, 2021. Financial Instruments Not Recorded at Fair Value on a Recurring Basis The Company reports financial instruments at fair value, with the exception of the 0% Convertible Senior Notes due December 1, 2026 (“Convertible Notes”). Financial instruments that are not recorded at fair value on a recurring basis are measured at fair value on a quarterly basis for disclosure purposes. The carrying values and estimated fair values of financial instruments not recorded at fair value are as follows: June 30, 2022 December 31, 2021 Carrying Value Fair Value Carrying Value Fair Value Convertible Notes $ 1,466,519 $ 1,100,625 $ 1,462,676 $ 1,462,676 The carrying value of the Convertible Notes as of June 30, 2022 and December 31, 2021 was net of unamortized debt issuance costs of $33,481 and $37,324, respectively. The total fair value of the Convertible Notes was determined based on the closing trading price as of the last day of trading for the period. The Company considers the fair value to be a Level 2 valuation due to the limited trading activity.

Debt

Debt	6 Months Ended
	Jun. 30, 2022
Debt Disclosure [Abstract]
Debt	Debt Credit Facility In February and March 2020, the Company entered into and subsequently amended a second amended and restated credit agreement with KeyBank National Association as administrative agent. In November 2021, the Company further amended such credit agreement to revise certain covenants that restricted the incurrence of indebtedness to permit the issuance of the convertible notes discussed below. In March 2022, the Company entered into a third amended and restated credit agreement (the “Credit Facility”) to, among other modifications, (i) remove the term loan component of the existing credit facility, which had been previously repaid in full; (ii) increase the maximum borrowing limit of the revolving credit facility from $150,000 to $250,000; (iii) extend the maturity date; (iv) replace the existing maximum total net leverage ratio financial covenant with a maximum senior secured net leverage ratio financial covenant; (v) eliminate the financial covenant requirement of maintaining a minimum debt service coverage ratio; (vi) reduce the interest rates applicable to any principal amounts outstanding on the revolving credit facility as well as the annual commitment fee for unused amounts on the revolving credit facility; and (vii) replace the benchmark reference rate for U.S. Dollar loans from LIBOR to the forward-looking term rate based on the secured overnight financing rate plus a customary adjustment (“Adjusted Term SOFR”). At June 30, 2022, the Company had available borrowing capacity of $250,000 on the Credit Facility. The Credit Facility will mature on the earlier of (a) March 29, 2027 and (b) 90 days before the maturity date applicable to any outstanding convertible notes issued by the Company in an aggregate principal amount equal to or greater than $100,000. The Credit Facility is secured by a first-priority security interest in substantially all of the assets of the Company. The Credit Facility contains certain financial and operational covenants, including a maximum senior secured net leverage ratio financial covenant of 3.50x. As of June 30, 2022, the Company was in compliance with all covenants under the Credit Facility. The per annum interest rate applicable to any principal amounts outstanding under the Credit Facility for U.S. Dollar loans will be equal to (i) Adjusted Term SOFR plus (ii) an applicable margin varying from 1.25% to 2.00%, subject to a pricing grid based on the senior secured net leverage ratio. The Credit Facility provides for an annual commitment fee varying from 0.20% to 0.30%, also subject to a pricing grid based on the senior secured net leverage ratio, applied to the average daily unused amount of the revolving credit facility. The Company incurred commitment fees on the unused balance of the Credit Facility of $126 and $103 for the three months ended June 30, 2022 and 2021, respectively, and $221 and $170 for the six months ended June 30, 2022 and 2021, respectively. In connection with the Credit Facility, the Company incurred $1,218 of additional debt issuance costs which, together with $662 of the then unamortized financing fees, will be amortized over the remaining term of the facility. The Company recognized a loss on extinguishment of debt of $407 for the six months ended June 30, 2022. The loss on extinguishment of debt represent a non-cash adjustment to reconcile net income to net cash provided by operating activities within the Condensed Consolidated Statements of Cash Flows. Amortization of deferred financing fees for the three months ended June 30, 2022 and 2021 was $95 and $90, respectively, and $187 and $2,063 for the six months ended June 30, 2022 and 2021, respectively. Convertible Notes In November 2021, the Company issued $1,500,000 aggregate principal amount of Convertible Notes in a private offering, including the exercise in full of the over-allotment option granted to the initial purchasers of $200,000. The Convertible Notes are senior unsecured obligations of the Company and do not bear regular interest, and the principal amount of the Convertible Notes does not accrete. The Convertible Notes will mature on December 1, 2026 unless earlier converted, redeemed, or repurchased. The net proceeds from this offering were $1,461,795 after deducting underwriting fees, expenses and commissions. Amortization of deferred financing fees for the three and six months ended June 30, 2022 was $1,863 and $3,731, respectively. Each $1,000 of principal of the Convertible Notes will initially be convertible into 5.6018 shares of the Company’s common stock, which is equivalent to an initial conversion price of approximately $178.51 per share, subject to adjustment as set forth in the indenture governing the Convertible Notes. Holders of these Convertible Notes may convert their Convertible Notes at their option at any time prior to the close of the business day immediately preceding June 1, 2026, only under the following circumstances: 1. during any calendar quarter commencing after the calendar quarter ending on March 31, 2022, if the last reported sale price of the Company’s common stock exceeds 130% of the conversion price for each of at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter on each applicable trading day; 2. during the five business day period after any ten consecutive trading day period (such ten consecutive trading day period, the “measurement period”) in which the trading price of the Convertible Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of the common stock on such trading day and the conversion rate on such trading day; 3. if the Company calls such Convertible Notes for redemption, at any time prior to the close of business on the business day immediately preceding the redemption date; and 4. upon the occurrence of specified corporate events or distributions on the common stock. As none of the above circumstances have occurred as of June 30, 2022, the Convertible Notes were not convertible for the fiscal quarter ending June 30, 2022. On or after June 1, 2026 until the close of business on the scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their Convertible Notes at the option of the holder regardless of the foregoing circumstances. Upon conversion of the Convertible Notes, the Company will pay or deliver, as the case may be, cash, shares of common stock or a combination of cash and shares of common stock, at the Company’s election. It is the Company's current intent to settle the principal amount of the Convertible Notes with common stock. The Company may redeem for cash all or any portion of the Convertible Notes, at its option, on or after December 2, 2024 and on or before the 25th scheduled trading day immediately before the maturity date, if the last reported sale price per share of the Company’s common stock exceeds 130% of the conversion price then in effect on each of at least 20 trading days (whether or not consecutive) during the 30 consecutive trading days ending on, and including, the trading day immediately preceding the date on which the Company provides a notice of redemption at a redemption price equal to 100% of the principal amount of the Convertible Notes to be redeemed, plus any accrued and unpaid special interest and additional interest, if any, to, but excluding, the redemption date. Upon the occurrence of a fundamental change (as defined in the indenture governing the Convertible Notes), subject to certain conditions, holders may require the Company to repurchase all or a portion of the Convertible Notes for cash at a price equal to 100% of the principal amount of the Convertible Notes to be repurchased, plus any accrued and unpaid special interest and additional interest, if any, to, but excluding, the fundamental change repurchase date.

Operating Leases

Operating Leases	6 Months Ended
	Jun. 30, 2022
Leases [Abstract]
Operating Leases	Operating Leases The Company leases data center facilities and office space under generally non-cancelable operating lease agreements, which expire at various dates through 2027. Facility leases generally include renewal options and may include escalating rental payment provisions. Additionally, the leases may require us to pay a portion of the related operating expenses. Rent expense related to these operating leases for the three months ended June 30, 2022 and 2021 was $12,422 and $12,340, respectively, and $24,831 and $24,330 for the six months ended June 30, 2022 and 2021, respectively. The Company entered into separate sublease agreements related to its New York office space effective as of March 2022 and June 2022, respectively. As defined within the lease and sublease agreements, the Company remains primarily liable to the landlord for the performance of all obligations in the event that the sublessees do not perform their obligations under their respective leases. As a result of the sublease arrangements, future minimum rental commitments under operating leases will be offset by sublease amounts to be paid by the sublessees. The Company recognized a loss on the sublease of $683 and $1,471 for the three and six months ended June 30, 2022. The total of minimum sublease amounts to be received in the future under non-cancelable subleases is $5,837 as of June 30, 2022. Future minimum rental payments under operating lease agreements, net of sublease payments, as of June 30, 2022, were as follows: 2022 (six months remaining) $ 23,403 2023 37,747 2024 38,789 2025 10,985 2026 8,215 Thereafter 2,314 Total minimum operating lease payments $ 121,453

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Purchase Commitments As of June 30, 2022, the Company had long-term commitments for bandwidth usage with various networks and internet service providers and entered into purchase orders with various vendors. The Company’s purchase commitments have not materially changed since December 31, 2021. Letters of Credit In conjunction with the execution of certain office space operating leases, letters of credit in the aggregate amount of $1,935 and $2,038 were issued and outstanding as of June 30, 2022 and December 31, 2021, respectively. No draws have been made under such letters of credit. These funds are included as Restricted cash on the Condensed Consolidated Balance Sheets as they are related to long-term operating leases and are included in beginning and ending Cash, cash equivalents and restricted cash in the Condensed Consolidated Statements of Cash Flows. Certain of the letters of credit can be reduced on an annual basis until the end of 2022, at which point the deposit required will similarly reduce to meet minimum threshold requirements. Legal Proceedings The Company may be involved in various legal proceedings and litigation arising in the ordinary course of business. While it is not feasible to predict or determine the ultimate disposition of any such litigation matters, the Company believes that any such legal proceedings will not have a material adverse effect on its condensed consolidated financial position, results of operations, or liquidity.

Stockholders_ Equity

Stockholders’ Equity	6 Months Ended
	Jun. 30, 2022
Equity [Abstract]
Stockholders’ Equity	Stockholders’ Equity Common Stock The Company’s amended and restated certificate of incorporation authorizes the issuance of common and preferred stock. Holders of common stock are entitled to one vote per share. As of June 30, 2022 and December 31, 2021, the Company was authorized to issue 750,000,000 shares of common stock with a par value of $0.000025 per share. Preferred Stock In connection with our initial public offering in March 2021 (“IPO”), the Company's amended and restated certificate of incorporation became effective, which authorized the issuance of 10,000,000 shares of preferred stock with a par value of $0.000025 per share with rights and preferences, including voting rights, designated from time to time by the Company's Board of Directors. No shares of preferred stock were issued or outstanding as of June 30, 2022 or December 31, 2021. Share Buyback Program On February 23, 2022, the Company's Board of Directors approved the repurchase of up to an aggregate of $300,000 of the Company’s common stock throughout fiscal year 2022 (“Previous Program”). As of May 16, 2022, the Company repurchased shares representing the entire amount available under the Previous Program. On May 23, 2022, the Company’s Board of Directors approved a new stock repurchase program authorizing the repurchase of up to an additional $300,000 of its common stock throughout fiscal year 2022 (the “Current Program”). Pursuant to the Current Program, repurchases of the Company's common stock will be made at prevailing market prices through open market purchases or in negotiated transactions off the market. The Current Program is authorized throughout fiscal year 2022; however, the Company is not obligated to acquire any particular amount of common stock and the Current Program may be extended, modified, suspended or discontinued at any time at the Company’s discretion. The Company repurchased and retired 9,970,473 and 12,547,944 shares of common stock in the open market for an aggregate purchase price of $400,000 and $550,000 during the three and six months ended June 30, 2022, respectively. All purchased shares were retired and are reflected as a reduction of Common stock for the par value of shares, with the excess applied to Additional paid-in capital. As of June 30, 2022, the dollar value of shares that remained available to be purchased by the Company under the Current Program was $50,000. Treasury Stock The Company records treasury stock at the cost to acquire shares and is included as a component of Stockholders’ equity. At June 30, 2022 and December 31, 2021, the Company had 1,968,228 shares of treasury stock which were carried at its cost basis of $4,598 on the Condensed Consolidated Balance Sheets. The Company’s Board of Directors approved to retire the balance of treasury stock as of August 1, 2022.

Stock-Based Compensation

Stock-Based Compensation	6 Months Ended
	Jun. 30, 2022
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation Equity Incentive Plan In March 2021, the Company’s Board of Directors adopted, and the stockholders approved, the 2021 Equity Incentive Plan. The 2021 Equity Incentive Plan is a successor to and continuation of the 2013 Stock Plan. The 2021 Equity Incentive Plan became effective on the date of the IPO with no further grants being made under the 2013 Stock Plan, however, awards outstanding under the 2013 Stock Plan will continue to be governed by their existing terms. The 2021 Equity Incentive Plan provides for the grant of incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock awards, restricted stock units awards (“RSUs”), performance awards, and other awards to employees, directors, and consultants up to an aggregate of 36,290,381 shares of common stock as of June 30, 2022. Shares issued pursuant to the exercise of these awards are transferable by the holder. Stock Options Stock options granted have a maximum term of ten years from the grant date, are exercisable upon vesting and vest over a period of four years. Stock option activity for the six months ended June 30, 2022 was as follows: Number of Options Outstanding Weighted-Average Exercise Price Weighted-Average Remaining Life in Years Aggregate Intrinsic Value Outstanding at January 1, 2022 12,434,159 $ 7.19 7.64 $ 909,494 Exercised (1,437,868) 5.95 Forfeited or cancelled (318,028) 8.35 Outstanding at June 30, 2022 10,678,263 7.32 7.16 363,517 Vested and exercisable at June 30, 2022 6,423,844 6.22 6.86 225,708 Vested and unvested expected to vest at June 30, 2022 9,669,916 $ 7.03 7.10 $ 332,012 The aggregate intrinsic value represents the difference between the fair value of common stock and the exercise price of outstanding in-the-money options. The aggregate intrinsic value of exercised options for the six months ended June 30, 2022 and 2021 was $70,497 and $48,516, respectively. No options were granted during the six months ended June 30, 2022 and 2021. The aggregate estimated fair value of stock options granted to participants that vested during the six months ended June 30, 2022 and 2021 was $9,169 and $9,275, respectively. As of June 30, 2022, there was $22,722 of unrecognized stock-based compensation related to outstanding stock options granted that is expected to be recognized over a weighted-average period of 2 years. RSUs RSUs granted vest over four years. RSU activity for the six months ended June 30, 2022 was as follows: Shares Weighted-Average Fair Value Unvested balance at January 1, 2022 3,334,137 $ 45.74 Granted 1,444,227 51.40 Vested (813,834) 41.43 Forfeited or cancelled (218,233) 47.22 Unvested balance at June 30, 2022 3,746,297 48.77 Vested and expected to vest at June 30, 2022 2,358,652 $ 49.15 As of June 30, 2022, there was $104,989 of unrecognized stock-based compensation related to outstanding RSUs granted that is expected to be recognized over a weighted-average period of 3.07 years. PRSUs The Company issued performance-based restricted stock units (“PRSUs”) which will vest based on the achievement of each award’s established performance targets. PRSU activity for the six months ended June 30, 2022 was as follows: Shares Weighted-Average Fair Value Unvested balance at January 1, 2022 578,949 $ 48.04 Granted 436,387 60.72 Vested (185,030) 48.33 Forfeited or cancelled (30,497) 41.24 Adjusted by performance factor (89,769) 41.24 Unvested balance at June 30, 2022 710,040 $ 56.94 At the end of each reporting period, the Company will adjust compensation expense for the PRSUs based on its best estimate of attainment of the below specified performance metrics. The cumulative effect on current and prior periods of a change in the estimated number of PRSUs that are expected to be earned during the performance period will be recognized as an adjustment to earnings in the period of the revision. Compensation cost in connection with the probable number of shares that will vest will be recognized using the accelerated attribution method. As of June 30, 2022, the Company determined that it was probable that the Long Term Incentive Plan (“LTIP”) PRSUs granted to certain executives of the Company with respect to the Company’s 2022 financial performance and the other PRSU awards would vest, resulting in $11,207 of unrecognized stock-based compensation that is expected to be recognized over a weighted-average period of 1.36 years. LTIP PRSUs The Company grants LTIP PRSUs to certain executives of the Company during the first fiscal quarter. A percentage of the LTIP PRSUs will become eligible to vest based on the Company’s financial performance level at the end of each fiscal year. The financial performance level is determined as the percentage equal to the sum of the revenue growth percentage and profitability percentage. The number of LTIP PRSUs received will depend on the achievement of financial metrics relative to the approved performance targets. Depending on the actual financial metrics achieved relative to the target financial metrics throughout the defined performance period of the award, the number of LTIP PRSUs that vest could range from 0% to 200% of the target amount, and are subject to the Board of Director’s approval of the level of achievement against the approved performance targets. Assuming the minimum performance target is achieved, one-third of the aggregate number of the LTIP PRSUs shall vest on the later of (i) March 1 or (ii) two trading days following the public release of the Company’s financial results, and the remainder shall vest in eight equal quarterly installments subject, in each case, to the individual’s continuous service through the applicable vesting. On February 24, 2022, the financial performance of the LTIP PRSUs granted in 2021 was determined to be achieved at 155% of the target amount. This resulted in a performance factor reduction of 89,769 shares from the original maximum shares achievable of 398,949. On March 1, 2022, the Company granted an LTIP PRSU award with a maximum shares achievable of 436,387, subject to the above actual financial metrics achieved relative to the target financial metrics for fiscal year 2022. Other PRSUs In addition to the above awards, certain other PRSUs have been awarded subject to other various performance measures including the achievement of revenue targets and product launches. On May 24, 2022, the financial performance of one of the Company’s other PRSUs was determined to be achieved at 100% of the target amount due to a successful product launch. On June 1, 2022, all 60,000 shares were fully vested. MRSUs On July 27, 2021, the Company’s Board of Directors granted a market-based restricted stock unit (“MRSU”) award for 3,000,000 shares of the Company’s common stock to the Company’s Chief Executive Officer, Yancey Spruill, which will vest upon the satisfaction of certain service conditions and the achievement of certain Company stock price goals, as described below. The MRSU, which has a grant date fair value of $75,300 derived by using a discrete model based on multiple stock price-paths developed through the use of a Monte Carlo simulation, is divided into five tranches that will be earned based on the achievement of stock price goals, measured based on the average of the Company’s closing stock price over a consecutive ninety (90) trading day period during the performance period as set forth in the table below. Tranche Company Stock Price Target Number of Eligible MRSUs 1 $93.50 475,000 2 $140.00 575,000 3 $187.00 650,000 4 $233.50 650,000 5 $280.50 650,000 To the extent earned based on the stock price targets set forth above, the MRSU will vest over a seven-year period beginning on the date of grant in annual amounts equal to 14%, 14%, 14%, 14%, 14%, 15% and 15%, respectively, on each anniversary of the date of grant. MRSU activity for the six months ended June 30, 2022 was as follows: Shares Weighted-Average Fair Value Unvested balance at January 1, 2022 3,000,000 $ 25.12 Granted — — Unvested balance at June 30, 2022 3,000,000 $ 25.12 As of June 30, 2022, there was $59,203 of unrecognized stock-based compensation related to the MRSUs granted that is expected to be recognized over a weighted-average period of 3.96 years. ESPP In March 2021, the Company’s Board of Directors adopted, and the stockholders approved, the 2021 Employee Stock Purchase Plan (“ESPP”). Eligible employees enroll in the offering period at the start of each purchase period, whereby they may purchase a number of shares at a price per share equal to 85% of the lesser of (1) the stock price at the employee’s first participation in the offering period or (2) the fair market value of the Company’s common stock on the purchase date. After the end of an offering period, a new offering will automatically begin on the date that immediately follows the conclusion of the preceding offering. The ESPP provides for the grant of up to an aggregate of 3,272,076 shares of common stock as of June 30, 2022. 2021 Offering The initial offering period commenced on the IPO date and consisted of two purchase periods, the first of which had a purchase date of November 19, 2021 and the second and final purchase period had a purchase date of May 20, 2022 (the “2021 Offering”). In connection with the purchase period that ended on November 19, 2021, there were 117,996 shares of common stock, net of shares withheld for taxes, purchased by employees at a price of $39.95. In connection with the purchase period that ended on May 20, 2022, there were 144,867 shares of common stock, net of shares withheld for taxes, purchased by employees at a price of $36.26. 2022 Offering A new offering period commenced on May 23, 2022 and will consist of two purchase periods, the first of which will have a purchase date of November 18, 2022 and the second and final purchase will have a purchase date of May 19, 2023 (the “2022 Offering”). As of June 30, 2022, 3,009,213 shares of common stock remain available for issuance under the ESPP. During the three and six months ended June 30, 2022, the Company recorded stock-based compensation associated with the ESPP of $1,178 and $2,539, respectively, and $1,922 for the three and six months ended June 30, 2021. As of June 30, 2022, $930 has been withheld on behalf of employees. Restricted Shares In connection with the acquisition of Nimbella, the Company issued 200,204 shares of restricted stock for $63.11 per share for a total value of $12,635 to the founders of Nimbella. These shares vest equally on March 1, 2023 and September 1, 2024 and are expensed on a straight line basis over 36 months. The restricted stock is subject to forfeiture and dependent upon each founder’s continuous service on the vesting date. Total stock-based compensation for the three and six months ended June 30, 2022 was $1,053 and $2,106, respectively. No stock-based compensation was recorded for the three and six months ended June 30, 2021. As of June 30, 2022, there was $9,142 of unrecognized stock-based compensation related to outstanding restricted shares granted that is expected to be recognized over a weighted-average period of 2.20 years. Stock-Based Compensation Stock-based compensation was included in the Condensed Consolidated Statements of Operations as follows: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Cost of revenue $ 481 $ 405 $ 913 $ 601 Research and development 10,661 5,059 20,381 7,695 Sales and marketing 3,851 1,902 7,197 3,039 General and administrative 13,190 4,835 25,673 7,490 Total $ 28,183 $ 12,201 $ 54,164 $ 18,825

Net Loss per Share Attributable

Net Loss per Share Attributable to Common Stockholders	6 Months Ended
	Jun. 30, 2022
Earnings Per Share [Abstract]
Net Loss per Share Attributable to Common Stockholders	Net Loss per Share Attributable to Common Stockholders The following table presents the calculation of basic and diluted net loss per share: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Numerator: Net loss attributable to common stockholders $ (6,191) $ (2,187) $ (24,314) $ (5,526) Denominator: Weighted average shares, in thousands, used to compute net loss per share, basic and diluted 102,502 106,765 104,697 78,257 Net loss per share attributable to common stockholders, basic and diluted $ (0.06) $ (0.02) $ (0.23) $ (0.07) Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows: June 30, 2022 2021 Warrants — 244,304 Stock Options 10,678,263 14,495,379 RSUs 3,746,297 2,769,723 PRSUs 710,040 318,754 MRSU 3,000,000 — ESPP 219,498 — Convertible Notes 8,402,700 — Total 26,756,798 17,828,160

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The computation of the provision for or benefit from income taxes for interim periods is determined by applying the estimated annual effective tax rate to year-to-date income (loss) before tax and adjusting for discrete tax items recorded in the period, if any. For the three and six months ended June 30, 2022, the Company recorded a tax benefit of $1,169 and a tax provision of $2,169, respectively. The effective tax rate for the three and six months ended June 30, 2022 was 15.9% and (9.8)%, respectively. The effective tax rate differs from the statutory rate primarily as a result of not recognizing deferred tax assets for U.S. losses due to a full valuation allowance against the U.S. deferred tax assets, and excess tax benefits from stock-based compensation. For the three and six months ended June 30, 2021, the Company recorded a tax benefit of $473 and a tax provision of $523, respectively. The effective tax rate for the three and six months ended June 30, 2021 was 17.8% and (10.5)%, respectively. The effective tax rate differs from the statutory rate primarily as a result of not recognizing deferred tax assets for U.S. losses due to a full valuation allowance against the U.S. deferred tax assets, and excess tax benefits from stock-based compensation. The provision for income taxes consists primarily of income taxes related to international jurisdictions in which the Company conducts business. Based on the available supporting evidence, including the amount and timing of future taxable income, the Company has concluded that it is more likely than not that a significant portion of the deferred tax assets will not be realized. As such, the Company maintains a full valuation allowance on its U.S. deferred tax assets. For the three and six months ended June 30, 2022, uncertain tax positions recorded by the Company resulted in an expense of $93 and $176, respectively. For the three and six months ended June 30, 2021, uncertain tax positions recorded by the Company resulted in an expense of $66 and $134, respectively. To the extent the remaining uncertain tax positions are ultimately recognized, the Company’s effective tax rate may be impacted in future periods. The Company’s policy is to recognize interest and penalties related to uncertain tax positions in income tax expense.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation and Principles of ConsolidationThe accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and include accounts of the Company and all wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of these condensed consolidated financial statements in conformity with U.S. GAAP requires management to make, on an ongoing basis, estimates, judgments and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Such estimates include, but are not limited to, those related to revenue recognition and allowance for doubtful accounts, useful lives and realizability of long-lived assets, capitalized internal-use software development costs, accounting for stock-based compensation, valuation allowances against deferred tax assets, fair value of marketable securities, the fair value and useful lives of tangible and intangible assets acquired and liabilities assumed resulting from business combinations. Management bases its estimates on historical experience and on various other assumptions which management believes to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.
Restricted Cash	Restricted CashRestricted cash includes deposits in financial institutions related to letters of credit used to secure lease agreements.
Marketable Securities	Marketable Securities The Company’s marketable securities consist of commercial paper, U.S. treasury securities and commercial debt securities. The Company determines the appropriate classification of its marketable securities at the time of purchase and reevaluates such designation at each balance sheet date. The Company has classified and accounted for its marketable securities as available-for-sale securities as the Company may sell these securities at any time for use in its current operations or for other purposes, even prior to maturity. As a result, the Company classifies its marketable securities within Current assets on the Condensed Consolidated Balance Sheets. Available-for-sale securities are recorded at fair value each reporting period. Premiums and discounts are amortized or accreted over the life of the related available-for-sale security as an adjustment to yield using the effective interest method. Interest income is recognized when earned. Unrealized gains and losses on these marketable securities are presented net of tax and reported as a separate component of Accumulated other comprehensive loss until realized. Realized gains and losses are determined based on the specific identification method and are reported in Other (income) expense, net in the Condensed Consolidated Statements of Operations. The Company periodically evaluates its marketable securities to assess whether an investment’s fair value is less than its amortized cost basis and if the decline in the fair value is attributable to a credit loss. Declines in fair value judged to be related to credit loss are reported in Other (income) expense, net in the Condensed Consolidated Statements of Operations.
Accounts Receivable and Allowance for Doubtful Accounts	Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable primarily represents revenue recognized that was not invoiced at the balance sheet date and is primarily billed and collected in the following month. Trade accounts receivable are carried at the original invoiced amount less an estimated allowance for doubtful accounts based on the probability of future collection. Management determines the adequacy of the allowance based on historical loss patterns, the number of days that customer invoices are past due and an evaluation of the potential risk of loss associated with specific accounts. When management becomes aware of circumstances that may further decrease the likelihood of collection, it records a specific allowance against amounts due, which reduces the receivable to the amount that management reasonably believes will be collected. The Company records changes in the estimate to the allowance for doubtful accounts through bad debt expense and reverses the allowance after the potential for recovery is considered remote.
Asset Acquisition	Asset Acquisition The Company applies the principles provided in ASC 805, Business Combinations ("ASC 805") to determine whether a transaction involves an asset or a business. If it is determined an acquisition is an asset acquisition, the purchase consideration (which will include certain transaction costs) is allocated to the acquired assets and liabilities based on their relative fair values.
Segment Information	Segment Information The Company’s chief operating decision maker, the chief executive officer, reviews discrete financial information presented on a consolidated basis for purposes of regularly making operating decisions, allocation of resources, and assessing financial performance. Accordingly, the Company has one operating and reporting segment.
Concentration of Credit Risk	Concentration of Credit Risk The amounts reflected in the Condensed Consolidated Balance Sheets for cash and cash equivalents, marketable securities, restricted cash, and trade accounts receivable are exposed to concentrations of credit risk. Although the Company maintains cash and cash equivalents with multiple financial institutions, the deposits, at times, may exceed federally insured limits. The Company believes that the financial institutions that hold its cash and cash equivalents are financially sound and, accordingly, minimal credit risk exists with respect to these balances.
Sublease	Sublease A sublease liability is recorded when the Company ceases to use leased space, which is included as Other current liabilities and Other noncurrent liabilities on the Condensed Consolidated Balance Sheets. A sublease loss is calculated as the present value of lease payments, net of expected sublease income, and other costs that do not have future economic benefit to the Company. The sublease loss is included in General and administrative on the Condensed Consolidated Statements of Operations.
Recent Accounting Pronouncements – Pending Adoption and Adopted	Recent Accounting Pronouncements – Pending Adoption The following effective dates represent the requirements for private companies which the Company has elected as an emerging growth company. In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2016-02, Leases (Topic 842), and additional changes, modifications, clarifications, or interpretations related to this guidance thereafter (“ASU 2016-02”). ASU 2016-02 requires a reporting entity to recognize right-of-use assets and lease liabilities on the balance sheet for operating leases to increase transparency and comparability. ASU 2016-02 is effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022 with early adoption permitted. The Company expects to elect the package of transition practical expedients, which allows it to carry forward its historical assessment of (1) whether contracts are or contain leases, (2) lease classification, and (3) initial direct costs. In addition, the Company expects to elect the practical expedient that allows lessees the option to account for lease and non-lease components together as a single component for all classes of underlying assets. The Company has made substantial progress in executing its implementation plan. It is in the process of revising its controls and processes to address the lease standard and is in the process of completing the implementation and data input for the lease accounting software tool that it will use post-adoption. ASU 2016-02 also requires expanded disclosure regarding the amounts, timing and uncertainties of cash flows related to a company’s lease portfolio. The Company is evaluating these disclosure requirements and is incorporating the collection of relevant data into its existing financial reporting processes. While the Company expects the adoption of this standard to result in an increase to the reported assets and liabilities, the Company is currently evaluating the impact of adoption on the condensed consolidated financial statements. In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805) Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (“ASU 2021-08”), to improve the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to the recognition of an acquired contract liability and to payment terms and their effect on subsequent revenue recognized by the acquirer. The amendments in ASU 2021-08 require that an entity (acquirer) recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. At the acquisition date, an acquirer should account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts. ASU 2021-08 is effective for fiscal years beginning after December 15, 2023 and early adoption is permitted. While the Company is continuing to assess the timing of adoption and the potential impacts of ASU 2021-08, it does not expect ASU 2021-08 to have a material effect on its consolidated financial statements and disclosures. In June 2016, the FASB issued ASU 2016-13, with subsequent amendments, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 requires immediate recognition of management’s estimates of current expected credit losses. ASU 2016-13 is effective for annual reporting periods beginning after December 15, 2022, and interim periods within annual periods beginning after December 15, 2023, with early adoption permitted. The Company is currently evaluating the impact of adoption on the condensed consolidated financial statements. Recent Accounting Pronouncements – Adopted In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”). ASU 2019-12 eliminates certain exceptions in FASB Topic 740: Income Taxes (“ASC 740”) related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other aspects of the accounting for income taxes. ASU 2019-12 is effective for annual reporting periods beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022, with early adoption permitted. The Company adopted the new standard and there was an immaterial impact to the condensed consolidated financial statements and related disclosures.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Reconciliation of Cash and Cash Equivalents	The following table reconciles cash, cash equivalents and restricted cash per the Condensed Consolidated Statements of Cash Flows: June 30, 2022 2021 Cash and cash equivalents $ 72,177 $ 577,218 Restricted cash 1,935 2,226 Total cash, cash equivalents and restricted cash $ 74,112 $ 579,444
Reconciliation of Restricted Cash	The following table reconciles cash, cash equivalents and restricted cash per the Condensed Consolidated Statements of Cash Flows: June 30, 2022 2021 Cash and cash equivalents $ 72,177 $ 577,218 Restricted cash 1,935 2,226 Total cash, cash equivalents and restricted cash $ 74,112 $ 579,444
Disclosure of Changes in Allowance for Doubtful Accounts	The following table presents the changes in our allowance for doubtful accounts for the period presented: Amount Balance as of December 31, 2021 $ 4,212 Bad debt expense, net of recoveries 8,070 Write-offs (6,967) Balance as of June 30, 2022 $ 5,315
Revenue by Geographic Areas	Revenue, as determined based on the billing address of the Company’s customers, was as follows: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 North America 38 % 38 % 38 % 38 % Europe 29 29 29 29 Asia 23 23 23 23 Other 10 10 10 10 Total 100 % 100 % 100 % 100 %

Balance Sheet Details (Tables)

Balance Sheet Details (Tables)	6 Months Ended
	Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Property and Equipment, Net	Property and equipment, net consisted of the following: June 30, 2022 December 31, 2021 Computers and equipment $ 544,056 $ 487,484 Furniture and fixtures 1,511 1,511 Leasehold improvements 6,820 6,820 Internal-use software 73,329 68,321 Property and equipment, gross $ 625,716 $ 564,136 Less: accumulated amortization $ (55,491) $ (49,268) Less: accumulated depreciation (301,807) (265,225) Property and equipment, net $ 268,418 $ 249,643

Marketable Securities (Tables)

Marketable Securities (Tables)	6 Months Ended
	Jun. 30, 2022
Investments, Debt and Equity Securities [Abstract]
Marketable Securities	The following is a summary of available-for-sale marketable securities, excluding those securities classified within cash and cash equivalents, on the Condensed Consolidated Balance Sheets as of June 30, 2022. The Company did not hold any available-for-sale marketable securities as of December 31, 2021. June 30, 2022 Amortized Gross Unrealized Gains Gross Unrealized Losses Fair U.S. treasury securities $ 708,226 $ 7 $ (2,783) $ 705,450 Corporate debt securities 35,121 — (297) 34,823 Commercial paper 355,018 — (1,314) 353,704 Total Marketable securities $ 1,098,365 $ 7 $ (4,394) $ 1,093,977

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2022
Fair Value Disclosures [Abstract]
Schedule of Liabilities Measured on a Recurring Basis	The fair value of our financial assets measured on a recurring basis is as follows: June 30, 2022 Level I Level II Total Cash and cash equivalents: Cash $ 68,551 $ — $ 68,551 Money market funds 3,626 — 3,626 Total Cash and cash equivalents $ 72,177 $ — $ 72,177 Marketable securities: U.S. treasury securities $ 705,450 $ — $ 705,450 Corporate debt securities — 34,823 34,823 Commercial paper — 353,704 353,704 Total Marketable securities $ 705,450 $ 388,527 $ 1,093,977 December 31, 2021 Level I Level II Total Cash and cash equivalents: Cash $ 1,093,425 $ — $ 1,093,425 Commercial paper — 269,945 269,945 Certificate of deposits — 350,017 350,017 Total Cash and cash equivalents $ 1,093,425 $ 619,962 $ 1,713,387 June 30, 2022 December 31, 2021 Carrying Value Fair Value Carrying Value Fair Value Convertible Notes $ 1,466,519 $ 1,100,625 $ 1,462,676 $ 1,462,676

Operating Leases (Tables)

Operating Leases (Tables)	6 Months Ended
	Jun. 30, 2022
Leases [Abstract]
Maturities of Operating Leases	Future minimum rental payments under operating lease agreements, net of sublease payments, as of June 30, 2022, were as follows: 2022 (six months remaining) $ 23,403 2023 37,747 2024 38,789 2025 10,985 2026 8,215 Thereafter 2,314 Total minimum operating lease payments $ 121,453

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	6 Months Ended
	Jun. 30, 2022
Share-based Payment Arrangement [Abstract]
Schedule of Stock Option Activity	Stock option activity for the six months ended June 30, 2022 was as follows: Number of Options Outstanding Weighted-Average Exercise Price Weighted-Average Remaining Life in Years Aggregate Intrinsic Value Outstanding at January 1, 2022 12,434,159 $ 7.19 7.64 $ 909,494 Exercised (1,437,868) 5.95 Forfeited or cancelled (318,028) 8.35 Outstanding at June 30, 2022 10,678,263 7.32 7.16 363,517 Vested and exercisable at June 30, 2022 6,423,844 6.22 6.86 225,708 Vested and unvested expected to vest at June 30, 2022 9,669,916 $ 7.03 7.10 $ 332,012
Schedule of RSU Activity	RSU activity for the six months ended June 30, 2022 was as follows: Shares Weighted-Average Fair Value Unvested balance at January 1, 2022 3,334,137 $ 45.74 Granted 1,444,227 51.40 Vested (813,834) 41.43 Forfeited or cancelled (218,233) 47.22 Unvested balance at June 30, 2022 3,746,297 48.77 Vested and expected to vest at June 30, 2022 2,358,652 $ 49.15
Schedule of PRSU Activity	PRSU activity for the six months ended June 30, 2022 was as follows: Shares Weighted-Average Fair Value Unvested balance at January 1, 2022 578,949 $ 48.04 Granted 436,387 60.72 Vested (185,030) 48.33 Forfeited or cancelled (30,497) 41.24 Adjusted by performance factor (89,769) 41.24 Unvested balance at June 30, 2022 710,040 $ 56.94
Summary of Share-Based Payment Arrangement and Price Targets	The MRSU, which has a grant date fair value of $75,300 derived by using a discrete model based on multiple stock price-paths developed through the use of a Monte Carlo simulation, is divided into five tranches that will be earned based on the achievement of stock price goals, measured based on the average of the Company’s closing stock price over a consecutive ninety (90) trading day period during the performance period as set forth in the table below. Tranche Company Stock Price Target Number of Eligible MRSUs 1 $93.50 475,000 2 $140.00 575,000 3 $187.00 650,000 4 $233.50 650,000 5 $280.50 650,000
Schedule of MRSU Activity	MRSU activity for the six months ended June 30, 2022 was as follows: Shares Weighted-Average Fair Value Unvested balance at January 1, 2022 3,000,000 $ 25.12 Granted — — Unvested balance at June 30, 2022 3,000,000 $ 25.12
Summary of Stock-Based Compensation Expense	Stock-based compensation was included in the Condensed Consolidated Statements of Operations as follows: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Cost of revenue $ 481 $ 405 $ 913 $ 601 Research and development 10,661 5,059 20,381 7,695 Sales and marketing 3,851 1,902 7,197 3,039 General and administrative 13,190 4,835 25,673 7,490 Total $ 28,183 $ 12,201 $ 54,164 $ 18,825

Net Loss per Share Attributab_2

Net Loss per Share Attributable to Common Stockholders (Tables)	6 Months Ended
	Jun. 30, 2022
Earnings Per Share [Abstract]
Schedule of Calculation of Basic and Diluted Net Loss Per Share	The following table presents the calculation of basic and diluted net loss per share: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Numerator: Net loss attributable to common stockholders $ (6,191) $ (2,187) $ (24,314) $ (5,526) Denominator: Weighted average shares, in thousands, used to compute net loss per share, basic and diluted 102,502 106,765 104,697 78,257 Net loss per share attributable to common stockholders, basic and diluted $ (0.06) $ (0.02) $ (0.23) $ (0.07)
Schedule of Anti-Dilutive Securities Excluded from Computation of Net Loss Per Share	Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows: June 30, 2022 2021 Warrants — 244,304 Stock Options 10,678,263 14,495,379 RSUs 3,746,297 2,769,723 PRSUs 710,040 318,754 MRSU 3,000,000 — ESPP 219,498 — Convertible Notes 8,402,700 — Total 26,756,798 17,828,160

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021	Jun. 30, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Cash and cash equivalents	$ 72,177	$ 1,713,387	$ 577,218
Restricted cash	1,935		2,226
Total cash, cash equivalents and restricted cash	$ 74,112	$ 1,715,425	$ 579,444	$ 102,537

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Disclosure of Changes in Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance	$ 4,212
Bad debt expense, net of recoveries	8,070	$ 3,467
Write-offs	(6,967)
Ending Balance	$ 5,315

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Revenue by Geographic Areas (Details) - Geographic Concentration Risk - Revenue from Contract with Customer	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration risk, percentage	100%	100%	100%	100%
North America
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration risk, percentage	38%	38%	38%	38%
Europe
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration risk, percentage	29%	29%	29%	29%
Asia
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration risk, percentage	23%	23%	23%	23%
Other
Revenues from External Customers and Long-Lived Assets [Line Items]
Concentration risk, percentage	10%	10%	10%	10%

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Narrative (Details) $ in Thousands	1 Months Ended		3 Months Ended		6 Months Ended
	Jun. 30, 2022 USD ($)	Mar. 31, 2021 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2022 USD ($) segment	Jun. 30, 2021 USD ($)	Dec. 31, 2021 USD ($)
Concentration Risk [Line Items]
Deferred revenue	$ 4,734		$ 4,734		$ 4,734		$ 4,826
Revenue recognized during period			$ 770	$ 634	$ 2,505	$ 2,359
Useful life					5 years
Purchase of intangible assets					$ 4,915	$ 0
Number of operating segments | segment					1
Number of reportable segments | segment					1
CSS Tricks
Concentration Risk [Line Items]
Cash consideration transferred		$ 4,000
JournalDev IT
Concentration Risk [Line Items]
Useful life					3 years
Purchase of intangible assets	$ 1,400
Geographic Concentration Risk | Revenue from Contract with Customer
Concentration Risk [Line Items]
Concentration risk, percentage			100%	100%	100%	100%
U.S. | Geographic Concentration Risk | Revenue from Contract with Customer
Concentration Risk [Line Items]
Concentration risk, percentage			32%		31%	31%
U.S. | Geographic Concentration Risk | Property and Equipment
Concentration Risk [Line Items]
Concentration risk, percentage					48%	50%

Balance Sheet Details - Schedul

Balance Sheet Details - Schedule of Property, Plant and Equipment (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 625,716	$ 564,136
Less: accumulated amortization	(55,491)	(49,268)
Less: accumulated depreciation	(301,807)	(265,225)
Property and equipment, net	268,418	249,643
Computers and equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	544,056	487,484
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,511	1,511
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	6,820	6,820
Internal-use software
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 73,329	$ 68,321

Balance Sheet Details - Narrati

Balance Sheet Details - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Depreciation	$ 20,701	$ 18,171	$ 41,027	$ 35,390
Capitalized computer software			5,128	3,034
Amortization expense related to internal-use software	$ 3,077	3,343	6,222	$ 7,000
Impairment loss		$ 0	$ 120

Marketable Securities (Details)

Marketable Securities (Details) $ in Thousands	3 Months Ended
	Jun. 30, 2022 USD ($)
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 1,098,365
Gross Unrealized Gains	7
Gross Unrealized Losses	(4,394)
Fair Value	1,093,977
U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	708,226
Gross Unrealized Gains	7
Gross Unrealized Losses	(2,783)
Fair Value	705,450
Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	35,121
Gross Unrealized Gains	0
Gross Unrealized Losses	(297)
Fair Value	34,823
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	355,018
Gross Unrealized Gains	0
Gross Unrealized Losses	(1,314)
Fair Value	$ 353,704

Marketable Securities - Narrati

Marketable Securities - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Investments, Debt and Equity Securities [Abstract]
Interest income	$ 2,644	$ 6	$ 3,590	$ 9

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Marketable securities:	$ 1,093,977
Fair Value, Recurring
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Cash and cash equivalents:	72,177	$ 1,713,387
Marketable securities:	1,093,977
Level I | Fair Value, Recurring
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Cash and cash equivalents:	72,177	1,093,425
Marketable securities:	705,450
Level II | Fair Value, Recurring
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Cash and cash equivalents:	0	619,962
Marketable securities:	388,527
Cash | Fair Value, Recurring
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Cash and cash equivalents:	68,551	1,093,425
Cash | Level I | Fair Value, Recurring
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Cash and cash equivalents:	68,551	1,093,425
Cash | Level II | Fair Value, Recurring
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Cash and cash equivalents:	0	0
Money market funds | Fair Value, Recurring
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Cash and cash equivalents:	3,626	269,945
Money market funds | Level I | Fair Value, Recurring
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Cash and cash equivalents:	3,626	0
Money market funds | Level II | Fair Value, Recurring
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Cash and cash equivalents:	0	269,945
Commercial paper
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Marketable securities:	353,704
Commercial paper | Fair Value, Recurring
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Cash and cash equivalents:		350,017
Marketable securities:	353,704
Commercial paper | Level I | Fair Value, Recurring
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Cash and cash equivalents:		0
Marketable securities:	0
Commercial paper | Level II | Fair Value, Recurring
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Cash and cash equivalents:		$ 350,017
Marketable securities:	353,704
U.S. treasury securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Marketable securities:	705,450
U.S. treasury securities | Fair Value, Recurring
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Marketable securities:	705,450
U.S. treasury securities | Level I | Fair Value, Recurring
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Marketable securities:	705,450
U.S. treasury securities | Level II | Fair Value, Recurring
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Marketable securities:	0
Corporate debt securities | Fair Value, Recurring
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Marketable securities:	34,823
Corporate debt securities | Level I | Fair Value, Recurring
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Marketable securities:	0
Corporate debt securities | Level II | Fair Value, Recurring
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Marketable securities:	$ 34,823

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021	Nov. 30, 2021
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Unamortized discount and debt issuance costs	$ 33,481	$ 37,324
Convertible Senior Notes Due 2026 | Senior Notes
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Interest rate			0%

Fair Value Measurements - Conve

Fair Value Measurements - Convertible Notes Measurement (Details) - Convertible Notes - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Convertible Notes	$ 1,466,519	$ 1,462,676
Fair Value, Recurring
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Convertible Notes	$ 1,100,625	$ 1,462,676

Debt - Narrative (Details)

Debt - Narrative (Details)	1 Months Ended	3 Months Ended		6 Months Ended
	Nov. 30, 2021 USD ($) d $ / shares	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)
Debt Instrument [Line Items]
Loss on extinguishment of debt		$ 0	$ 0	$ 407,000	$ 3,435,000
Interest and amortization of deferred financing fees		2,095,000	233,000	4,154,000	2,489,000
Proceeds from issuance of convertible notes, net of issuance costs	$ 1,461,795,000
Credit Facility
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity	250,000,000
Commitment fees on unused balance		126,000	103,000	221,000	170,000
Debt issuance costs		1,218,000		1,218,000
Financing fees		662,000		662,000
Interest and amortization of deferred financing fees				$ 187,000	$ 2,063,000
Amortization		95,000	$ 90,000
Credit Facility | KayBank National Association
Debt Instrument [Line Items]
Debt service coverage ratio				3.50
Credit Facility | Minimum
Debt Instrument [Line Items]
Debt instrument, face amount		100,000,000		$ 100,000,000
Credit Facility | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Variable Rate Component One | Minimum
Debt Instrument [Line Items]
Variable rate				1.25%
Credit Facility | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Variable Rate Component One | Maximum
Debt Instrument [Line Items]
Variable rate				2%
Term Loan
Debt Instrument [Line Items]
Loss on extinguishment of debt		407,000
Senior Notes | Convertible Senior Notes Due 2026
Debt Instrument [Line Items]
Debt instrument, face amount	$ 1,500,000,000
Interest and amortization of deferred financing fees		$ 1,863,000		$ 3,731,000
Conversion ratio, number of shares	5.6018
Conversion price | $ / shares	$ 178.51
Scheduled trading days	25 days
Redemption price, percentage	100%
Senior Notes | Convertible Senior Notes Due 2026 | Debt Conversion, Period One
Debt Instrument [Line Items]
Percentage of stock price trigger	130%
Trading days | d	20,000
Consecutive trading days | d	30,000
Senior Notes | Convertible Senior Notes Due 2026 | Debt Conversion, Period Two
Debt Instrument [Line Items]
Consecutive trading days | d	10,000
Business days after trading period | d	5,000
Redemption price, percentage	98%
Senior Notes | Convertible Senior Notes Due 2026 | Underwriters' Option
Debt Instrument [Line Items]
Consideration received	$ 200,000,000
Line of Credit | Credit Facility | Revolving Credit Facility
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity	$ 150,000,000
Line of Credit | Credit Facility | Revolving Credit Facility | Minimum
Debt Instrument [Line Items]
Commitment fee percentage				0.20%
Line of Credit | Credit Facility | Revolving Credit Facility | Maximum
Debt Instrument [Line Items]
Commitment fee percentage				0.30%

Operating Leases - Narrative (D

Operating Leases - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Leases [Abstract]
Operating leases, rent expense	$ 12,422	$ 12,340	$ 24,831	$ 24,330
Sublease loss	683		1,471
Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals	$ 5,837		$ 5,837

Operating Leases - Maturities o

Operating Leases - Maturities of Operating Leases (Details) $ in Thousands	Jun. 30, 2022 USD ($)
Leases [Abstract]
2022 (six months remaining)	$ 23,403
2023	37,747
2024	38,789
2025	10,985
2026	8,215
Thereafter	2,314
Total minimum operating lease payments	$ 121,453

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Letters of credit outstanding, amount	$ 1,935	$ 2,038

Stockholders_ Equity - Narrativ

Stockholders’ Equity - Narrative (Details) $ / shares in Units, $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2022 USD ($) $ / shares shares	Jun. 30, 2022 USD ($) vote $ / shares shares	May 23, 2022 USD ($)	Feb. 23, 2022 USD ($)	Dec. 31, 2021 USD ($) $ / shares shares	Jun. 30, 2021 $ / shares
Equity [Abstract]
Common stock, voting rights | vote		1
Common stock, shares authorized (in shares)	750,000,000	750,000,000
Common stock, par value (in dollars per share) | $ / shares					$ 0.000025	$ 0.000025
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, par value (in usd per share) | $ / shares	$ 0.000025	$ 0.000025			$ 0.000025
Preferred stock, shares outstanding (in shares)	0	0			0
Preferred stock, shares issued (in shares)	0	0			0
Stock repurchase program, authorized amount | $			$ 300,000	$ 300,000
Repurchase and retirement of common stock (in shares)	9,970,473	12,547,944
Repurchase and retirement of common stock | $	$ 400,000	$ 550,000
Remaining authorized purchase amount | $	$ 50,000	$ 50,000
Treasury stock, shares (in shares)	1,968,228	1,968,228			1,968,228
Treasury stock, at cost (1,968,228 shares at June 30, 2022 and December 31, 2021) | $	$ (4,598)	$ (4,598)			$ (4,598)

Stockholders_ Equity - Preferre

Stockholders’ Equity - Preferred Stock (Details) - $ / shares	Jun. 30, 2022	Dec. 31, 2021
Equity [Abstract]
Preferred stock, shares authorized (in shares)	10,000,000
Preferred stock, par value (in usd per share)	$ 0.000025	$ 0.000025
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0

Stockholders_ Equity - Redeemab

Stockholders’ Equity - Redeemable Convertible Preferred Stock (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Class of Stock [Line Items]
Conversion of convertible preferred stock to common stock in connection with initial public offering (in shares)	45,472,229
Conversion of convertible preferred stock	$ 173,074
Redeemable convertible preferred stock, outstanding (in shares)	0	45,472,229

Stockholders_ Equity - Treasury

Stockholders’ Equity - Treasury Stock (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Equity [Abstract]
Treasury stock, shares (in shares)	1,968,228	1,968,228
Treasury stock, value	$ (4,598)	$ (4,598)

Stock-Based Compensation - Equi

Stock-Based Compensation - Equity Incentive Plan (Details)	Jun. 30, 2022 shares
2021 Stock Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate number of shares of common stock awarded (in shares)	36,290,381

Stock-Based Compensation - Stoc

Stock-Based Compensation - Stock Options (Details) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, exercised in period, intrinsic value		$ 70,497	$ 48,516
Options, granted, number (in shares)				0
Stock options, granted in period, aggregate estimated fair value		9,169	$ 9,275
Stock options, unrecognized stock-based compensation expense	$ 22,722	$ 22,722		$ 22,722
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, expiration period				10 years
Stock options, vesting period				4 years
Unrecognized stock-based compensation expense, average recognition period	2 years

Stock-Based Compensation - Sche

Stock-Based Compensation - Schedule of Stock Option Activity (Details) $ / shares in Units, $ in Thousands		6 Months Ended
	Jan. 01, 2021	Jun. 30, 2022 USD ($) $ / shares shares
Number of Options Outstanding
Number of options outstanding at the beginning of the period (in shares) | shares		12,434,159
Exercised (in shares) | shares		(1,437,868)
Forfeited or cancelled (in shares) | shares		(318,028)
Number of options outstanding at the end of the period (in shares) | shares		10,678,263
Vested and exercisable at end of period (in shares) | shares		6,423,844
Vested and unvested expected to vest at end of period (in shares) | shares		9,669,916
Weighted-Average Exercise Price
Weighted-average exercise price outstanding at beginning of period (in dollars per share) | $ / shares		$ 7.19
Exercised (in dollars per share) | $ / shares		5.95
Forfeited or cancelled (in dollars per share) | $ / shares		8.35
Weighted-average exercise price outstanding at end of period (in dollars per share) | $ / shares		7.32
Vested and exercisable at end of period (in dollars per share) | $ / shares		6.22
Vested and unvested expected to vest at end of period (in dollars per share) | $ / shares		$ 7.03
Weighted-Average Remaining Life in Years
Weighted average remaining life (in years)	7 years 7 months 20 days	7 years 1 month 28 days
Vested and exercisable at end of period (in years)		6 years 10 months 9 days
Vested and unvested expected to vest at end of period (in years)		7 years 1 month 6 days
Aggregate Intrinsic Value
Aggregate intrinsic value at beginning of period | $		$ 909,494
Aggregate intrinsic value at end of period | $		363,517
Vested and exercisable at June 30, 2022 | $		225,708
Vested and unvested expected to vest at June 30, 2022 | $		$ 332,012

Stock-Based Compensation - RSUs

Stock-Based Compensation - RSUs (Details) - RSUs $ in Thousands	6 Months Ended
	Jun. 30, 2022 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
RSUs, vesting period	4 years
Unrecognized stock-based compensation expense	$ 104,989
Unrecognized stock-based compensation expense, average recognition period	3 years 25 days

Stock-Based Compensation - Sc_2

Stock-Based Compensation - Schedule of RSU & PRSU Activity (Details) - $ / shares		6 Months Ended
	Jun. 01, 2022	Jun. 30, 2022
Weighted-Average Fair Value
Forfeited or cancelled (in dollars per share)		$ 8.35
RSUs
Shares
Unvested balance at beginning of period (in shares)		3,334,137
Granted (in shares)		1,444,227
Vested (in shares)		(813,834)
Forfeited or cancelled (in shares)		(218,233)
Unvested balance at end of period (in shares)		3,746,297
Vested and expected to vest (in shares)		2,358,652
Weighted-Average Fair Value
Unvested balance at beginning of period (in dollars per share)		$ 45.74
Granted (in dollars per share)		51.40
Vested (in dollars per share)		41.43
Forfeited or cancelled (in dollars per share)		47.22
Unvested balance at end of period (in dollars per share)		48.77
Vested and expected to vest (in dollars per share)		$ 49.15
PRSUs
Shares
Unvested balance at beginning of period (in shares)		578,949
Granted (in shares)		436,387
Vested (in shares)	(60,000)	(185,030)
Forfeited or cancelled (in shares)		(30,497)
Adjusted by performance factor		(89,769)
Unvested balance at end of period (in shares)		710,040
Weighted-Average Fair Value
Unvested balance at beginning of period (in dollars per share)		$ 48.04
Granted (in dollars per share)		60.72
Vested (in dollars per share)		48.33
Forfeited or cancelled (in dollars per share)		41.24
Adjusted for performance factor (in usd per share)		41.24
Unvested balance at end of period (in dollars per share)		$ 56.94

Stock-Based Compensation - PRSU

Stock-Based Compensation - PRSUs (Details) $ in Thousands							6 Months Ended
	Jun. 01, 2022 shares	May 24, 2022	Mar. 01, 2022 shares	Feb. 24, 2022 shares	Jul. 27, 2021 segment	Jun. 10, 2021 segment	Jun. 30, 2022 USD ($) shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of trading days | segment					90
Options, granted, number (in shares)							0
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage							200%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage							0%
PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized stock-based compensation expense | $							$ 11,207
Unrecognized stock-based compensation expense, average recognition period							1 year 4 months 9 days
Number of quarterly installments | segment						8
Percentage of target award (in percent)		100%		15,500%
Increase (decrease) in performance factor (in shares)				89,769
Options, granted, number (in shares)				398,949
Vested (in shares)	60,000						185,030
PRSUs | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of trading days | segment						2
Options, granted, number (in shares)			436,387

Stock-Based Compensation - MRSU

Stock-Based Compensation - MRSUs (Details) $ in Thousands		6 Months Ended
	Jul. 27, 2021 USD ($) tranche segment shares	Jun. 30, 2022 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of trading days | segment	90
MRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock reserved for future issuance, number available for grant (in shares) | shares	3,000,000
Grant date fair value	$ 75,300
Number of tranches | tranche	5
Stock options, vesting period		7 years
Unrecognized stock-based compensation expense		$ 59,203
Weighted-average period expected for recognition of compensation expense		3 years 11 months 15 days
MRSUs | 1
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	14%
MRSUs | 2
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	14%
MRSUs | 3
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	14%
MRSUs | 4
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	14%
MRSUs | 5
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	14%
MRSUs | 6
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	15%
MRSUs | 7
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	15%

Stock-Based Compensation - MR_2

Stock-Based Compensation - MRSUs Share-Based Payment Arrangements and Price Targets (Details) - MRSUs	Jul. 27, 2021 $ / shares shares
1
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Company stock price target (in dollars per share) | $ / shares	$ 93.50
Number of eligible MRSUs (in shares) | shares	475,000
2
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Company stock price target (in dollars per share) | $ / shares	$ 140
Number of eligible MRSUs (in shares) | shares	575,000
3
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Company stock price target (in dollars per share) | $ / shares	$ 187
Number of eligible MRSUs (in shares) | shares	650,000
4
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Company stock price target (in dollars per share) | $ / shares	$ 233.50
Number of eligible MRSUs (in shares) | shares	650,000
5
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Company stock price target (in dollars per share) | $ / shares	$ 280.50
Number of eligible MRSUs (in shares) | shares	650,000

Stock-Based Compensation - Sc_3

Stock-Based Compensation - Schedule of MRSU Activity (Details) - MRSU	6 Months Ended
	Jun. 30, 2022 $ / shares shares
Shares
Unvested balance at beginning of period (in shares) | shares	3,000,000
Granted (in shares) | shares	0
Unvested balance at end of period (in shares) | shares	3,000,000
Weighted-Average Fair Value
Unvested balance at beginning of period (in dollars per share) | $ / shares	$ 25.12
Granted (in dollars per share) | $ / shares	0
Unvested balance at end of period (in dollars per share) | $ / shares	$ 25.12

Stock-Based Compensation - ESPP

Stock-Based Compensation - ESPP and RSUs (Details) - USD ($)				3 Months Ended		6 Months Ended
	May 20, 2022	Nov. 19, 2021	Sep. 01, 2021	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Mar. 31, 2022	Sep. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense				$ 28,183,000	$ 12,201,000	$ 54,164,000	$ 18,825,000
IPO
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based award, amount withheld for employees						$ 930,000
2021 Employee Stock Purchase Plan | Employee Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Purchase price of common stock, percent		85%
Shares of common stock authorized for future issuance (in shares)									3,272,076
Issuance of common stock under employee stock purchase plan, net of taxes withheld (in shares)	144,867	117,996
Purchase price of shares (in usd per share)	$ 36.26	$ 39.95
Shares of common stock reserved for future issuance, number available for grant (in shares)				3,009,213		3,009,213
Stock-based compensation expense				$ 1,178,000	1,922,000	$ 2,539,000	1,922,000
2021 Employee Stock Purchase Plan | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense				1,053,000	$ 0	2,106,000	$ 0
Acquisition of Nimbella | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)			200,204
Restricted stock share price (in dollars per share)								$ 63.11
Value of restricted stock granted to founders of Nimbella				$ 12,635,000
Stock options, vesting period				36 months
Unrecognized stock-based compensation expense				$ 9,142,000		$ 9,142,000
Weighted-average period expected for recognition of compensation expense						2 years 2 months 12 days

Stock-Based Compensation - Summ

Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 28,183	$ 12,201	$ 54,164	$ 18,825
Cost of Sales [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	481	405	913	601
Research and Development Expense [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	10,661	5,059	20,381	7,695
Selling and Marketing Expense [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	3,851	1,902	7,197	3,039
General and Administrative Expense [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 13,190	$ 4,835	$ 25,673	$ 7,490

Net Loss per Share Attributab_3

Net Loss per Share Attributable to Common Stockholder - Schedule of Net Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Numerator:
Net loss attributable to common stockholders, basic	$ (6,191)	$ (2,187)	$ (24,314)	$ (5,526)
Net loss attributable to common stockholders, diluted	$ (6,191)	$ (2,187)	$ (24,314)	$ (5,526)
Denominator:
Weighted average shares used to compute net loss per share, basic (in shares)	102,502,000	106,765,000	104,697,000	78,257,000
Weighted average shares used to compute net loss per share, diluted (in shares)	102,502,000	106,765,000	104,697,000	78,257,000
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.06)	$ (0.02)	$ (0.23)	$ (0.07)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.06)	$ (0.02)	$ (0.23)	$ (0.07)

Net Loss per Share Attributab_4

Net Loss per Share Attributable to Common Stockholder - Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share (Details) - shares	3 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of loss per share, amount (in shares)	26,756,798	17,828,160
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of loss per share, amount (in shares)	0	244,304
Stock Options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of loss per share, amount (in shares)	10,678,263	14,495,379
RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of loss per share, amount (in shares)	3,746,297	2,769,723
PRSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of loss per share, amount (in shares)	710,040	318,754
MRSU
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of loss per share, amount (in shares)	3,000,000	0
ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of loss per share, amount (in shares)	219,498	0
Convertible Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of loss per share, amount (in shares)	8,402,700	0

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Tax Disclosure [Abstract]
Income tax (benefit) expense	$ (1,169)	$ (473)	$ 2,169	$ 523
Effective income tax rate	15.90%	17.80%	(9.80%)	(10.50%)
Uncertain tax positions expense	$ 93	$ 66	$ 176	$ 134